Preparation and characterization of radioligands for the orphan receptor GPR88
Preparation and characterization of radioligands for the orphan receptor GPR88
批准号:
10038885
负责人:
David Hesk
金额:
$22.02万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-10 至 2022-08-31
关键词:
AffinityAgonistAlcohol consumptionAnxietyAreaAutoradiographyAwardBindingBinding ProteinsBinding SitesBiodistributionBiological AssayBiological ProcessBrainChildhoodChoreaCollaborationsCommunitiesComputer ModelsCorpus striatum structureCost SavingsCyclic AMPDiseaseDissociationDorsalDrug AddictionDrug DesignFundingG-Protein-Coupled ReceptorsGene Expression ProfilingGenesGeneticGenetic RiskGenetic studyGenomeGoalsGrantHigh Pressure Liquid ChromatographyHuman GeneticsI125 isotopeImmunohistochemistryIn VitroInvestigationIon ChannelKineticsKnock-inKnock-outKnowledgeLabelLearning DisabilitiesLicensingLigand BindingLigandsLinkMapsMediatingMediationMethodsMusNeuronsOrphanParkinson DiseasePathway interactionsPharmaceutical ChemistryPharmacologyPilot ProjectsPlayPositioning AttributePreparationPropertyProtein KinaseProteinsRadioactiveRadioactivityRattusRegulationResearchRodentRoleSchizophreniaShippingSignal PathwaySignal TransductionSiteSpeech DelayStructureStructure-Activity RelationshipSystemTechniquesTherapeuticTritiumVariantVenusalcohol seeking behavioranaloganimal databasedensitydesigndisorder riskdrug discoveryexperienceexperimental studyfallsgenome resourcehuman dataimprovedin vivoinsightinterestnew therapeutic targetnovelprogramsradiochemicalradioligandradiotracerreceptorreceptor bindingreceptor functionresponsescaffoldsmall moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This application is in response to RFA-RM-19-011, which aims to support pilot projects for the Common Fund
Program "Illuminating the Druggable Genome" (IDG) to study IDG-eligible understudied GPCRs, protein kinases,
and ion channels. The orphan receptor GPR88 is an IDG-eligible GPCR with robust expression in the striatum
throughout the dorsal and ventral areas. Multiple lines of evidence suggest that GPR88 plays an important role
in the regulation of striatal functions and is implicated in a number of disorders such as Parkinson’s disease,
schizophrenia, anxiety, and drug addiction. To date, the endogenous ligand for GPR88 has not been discovered.
In order to characterize GPR88 signaling mechanisms and biological functions, our group has carried out a
medicinal chemistry campaign to develop GPR88 small-molecule agonist probes. We have recently developed
the first highly potent, selective, and brain-penetrant GPR88 agonist RTI-33 that has GPR88 on-target in vivo
activity in reducing alcohol drinking and seeking behaviors in rats and mice. However, the pharmacology of the
receptor and its mechanism of action are still largely unknown, thus limiting exploration of its potential for
therapeutic applications. In this regard, a suitable radioligand, that is currently unavailable, will be a powerful tool
for ligand-receptor interactions studies and for autoradiography to map the receptor binding sites in the brain,
which can be used to predict the potential functions of the receptor and guide in vivo studies. In Aim 1, we will
optimize and synthesize tritium-labeled RTI-33 radioligands with suitable radiochemical purity and specific
radioactivity for receptor binding studies. In Aim 2, we will characterize the receptor binding properties using
saturation, kinetic, and competition binding experiments. Overall, completion of this grant will provide GPR88
radioligands to serve IDG and the research community in an effort to further characterize the GPR88 system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: